CTEPHNCT06865326
Early Detection of CTEPH in Patients After APE
StatusRecruiting
PhaseNot specified
Primary completion (estimated)
At risk: Primary completion moved 1 year 7 months later.
See at-risk trials from Institute of Health Information and Statistics of the Czech Republic
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Primary completion pushed from May 31, 2026 to Dec 31, 2027
- Eligibility criteria expanded, about 15 words
- Study completion pushed from Dec 1, 2026 to Jun 30, 2028
- Study description revised
Notable Phase: Not applicable to Not specifiedv2 Show 4 more changesShow less
- Trial status: Not Yet Recruiting to Recruiting
- Study sites: 0 to 10
- Start date changed from estimate of Feb 28, 2025 to Mar 7, 2025
- Study description revised
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Positive predictive value of initial examination
Timeframe: Up to six months from enrollment
CTEPH detection rates
Timeframe: Up to six months from enrollment
Proportion of people with suspected CTEPH who attended a follow-up examination at a specialized pulmonary hypertension treatment centre
Timeframe: Up to six months from enrollment
Arms and interventions
CTEPH Screening Arm
Patients after APE matching all inclusion \& exclusion criteria will undergo a standardized screening process for early detection of CTEPH. The process will include the new screening protocol and in case of a risk of CTEPH, transfer to specialized center for further management.
Other: Standardized CTEPH Screening Protocol
Sites
10 sites in 1 country